Page last updated: 2024-08-23

propiconazole and selenium

propiconazole has been researched along with selenium in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Fratianni, C; Gonzales, M; Khardori, R; Mamillapali, C1
Casini, G; Cestari, L; Latrofa, F; Leo, M; Marcocci, C; Marinò, M; Nardi, M; Rotondo Dottore, G; Sellari-Franceschini, S; Vitti, P1
Casini, G; Cestari, L; Chiarini, R; De Gregorio, M; Leo, M; Marcocci, C; Marinò, M; Nardi, M; Rotondo Dottore, G; Sellari-Franceschini, S; Vitti, P1
Eckstein, A; Führer, D; Möller, L; Oeverhaus, M1

Reviews

2 review(s) available for propiconazole and selenium

ArticleYear
Immunotherapy in miscellaneous medical disorders Graves ophthalmopathy, asthma, and regional painful syndrome.
    The Medical clinics of North America, 2012, Volume: 96, Issue:3

    Topics: Allergens; Anti-Asthmatic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antioxidants; Asthma; Azathioprine; Benzamides; Complex Regional Pain Syndromes; Cyclosporine; Decompression, Surgical; Etanercept; Glucocorticoids; Graves Ophthalmopathy; Humans; Imatinib Mesylate; Immunoglobulin G; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Octreotide; Omalizumab; Orbit; Piperazines; Pyridones; Pyrimidines; Radiotherapy Dosage; Receptors, Tumor Necrosis Factor; Risk Factors; Rituximab; Selenium

2012
[Graves' orbitopathy].
    Deutsche medizinische Wochenschrift (1946), 2021, Volume: 146, Issue:20

    Topics: Administration, Intravenous; Antibodies, Monoclonal, Humanized; Antioxidants; Decompression, Surgical; Graves Ophthalmopathy; Humans; Lubricant Eye Drops; Orbit; Receptor, IGF Type 1; Risk Factors; Selenium; Smoking Cessation; Steroids

2021

Other Studies

2 other study(ies) available for propiconazole and selenium

ArticleYear
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy.
    Thyroid : official journal of the American Thyroid Association, 2017, Volume: 27, Issue:2

    Topics: Aged; Antioxidants; Case-Control Studies; Cell Proliferation; Cells, Cultured; Cytokines; Female; Fibroblasts; Glutathione Disulfide; Glutathione Peroxidase; Graves Ophthalmopathy; Humans; Hyaluronic Acid; Hydrogen Peroxide; Male; Middle Aged; Orbit; Oxidants; Oxidative Stress; Selenium; Selenocysteine

2017
Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves' orbitopathy.
    Endocrine, 2017, Volume: 58, Issue:2

    Topics: Adipose Tissue; Aged; Cell Death; Cells, Cultured; Cytoprotection; Female; Fibroblasts; Graves Ophthalmopathy; Humans; Hydrogen Peroxide; Male; Middle Aged; Orbit; Primary Cell Culture; Selenium; Signal Transduction

2017